The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion

Anesthesia and Analgesia

Volumn 109, Issue 5, 2009, Pages 1486-1492

  Assad, Alexandra R ^a   Delou, João Marcos A ^a   Fonseca, Leonardo M ^a   Villela, Nivaldo R ^a   Nascimento, José Hamilton M ^a   Verçosa, Nubia ^a   Lopes, Anibal Gil ^a   Capella, Márcia A M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANTIMYCIN A1; DIAZOXIDE; DIMETHYLTHIAZOLDIPHENYLTETRAZOL BROMIDE; DYE; FLUORESCEIN ISOTHIOCYANATE; GLIBENCLAMIDE; LIPOCORTIN 5; PROPOFOL; TRYPAN BLUE; UNCLASSIFIED DRUG; 5 HYDROXYDECANOIC ACID; 5-HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; DECANOIC ACID DERIVATIVE; HYDROXYACID; POTASSIUM CHANNEL BLOCKING AGENT; PROTECTIVE AGENT;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL STRAIN; CELL STRAIN LLC PK1; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY ISCHEMIA; PRIORITY JOURNAL; RENAL PROTECTION; ANIMAL; CELL PROTECTION; CELL SURVIVAL; DRUG EFFECT; DRUG POTENTIATION; KIDNEY; KIDNEY DISEASE; METABOLISM; NECROSIS; PATHOLOGY; REPERFUSION INJURY; SWINE; TIME;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIMYCIN A; APOPTOSIS; CELL SURVIVAL; CYTOPROTECTION; DECANOIC ACIDS; DIAZOXIDE; GLYBURIDE; HYDROXY ACIDS; KATP CHANNELS; KIDNEY; KIDNEY DISEASES; LLC-PK1 CELLS; NECROSIS; POTASSIUM CHANNEL BLOCKERS; PROPOFOL; PROTECTIVE AGENTS; REPERFUSION INJURY; SWINE; TIME FACTORS;

EID: 70350706111     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181b76396     Document Type: Article

References (40)

1. Iijima T, Mishima T, Akagawa K, Iwao Y. Neuroprotective effect of propofol on necrosis and apoptosis following oxygen-glucose deprivation- relationship between mitochondrial membrane potential and mode of death. Brain Res 2006;1099:25-32
2. Kobayashi I, Kokita N, Namiki A. Propofol attenuates ischemiareperfusion injury in the rat heart in vivo. Eur J Anaesthesiol 2008;25:144-151
3. Azeredo MAI, Azeredo LAI, Eleuthério ECA, Schanaider A. Propofol and N-acetylcysteine attenuate oxidative stress induced by intestinal ischemia/reperfusion in rats. Protein. Acta Cirúrgica Brasileira 2008;23:425-428
4. Balyasnikova IV, Visintine DJ, Gunnerson HB, Paisansathan C, Baugluman VL, Minshall RD, Danilov SM. Propofol attenuates lung endothelial injury induced by ischemia-reperfusion and oxidative stress. Anesth Analg 2005;100:929-936
5. Wang H, Zhou H, Chen C, Zhang X, Cheng G. Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1. Acta Pharmacol Sin 2007;28:1175-1180
6. Soullier S, Gayrard N, Méjean C, Swarcz I, Mourad G, Argilés A. Molecular mechanisms involved in kidney ischemia-reperfusion. Nephrol Ther 2005;1:315-321
7. Toronyi E. Role of apoptosis in the kidney after reperfusion. Orv Hetil 2008;149:305-315
8. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 2000;278:F380-7
9. Kirpatovskii VI, Kazachenko AV, Plotnikov EY, Kon'kova TA, Drozhzheva VV, Zorov DB. Effects of ischemic and hypoxic preconditioning on the state of mitochondria and function of ischemic kidneys. Bull Exp Biol Med 2007;143:105-109
10. Jiang K, Yu ZS, Shui QX, Xia ZZ. Activation of ATP-sensitive potassium channels prevents the cleavage of cytosolic mucalpain and abrogates the elevation of nuclear c-Fos and c-Jun expressions after hypoxic-ischemia in neonatal rat brain. Brain Res Mol Brain Res 2005;133:87-94
11. Zhuo ML, Huang Y, Liu DP, Liang CC. KATP channel: relation with cell metabolism and role in the cardiovascular system. Int J Biochem Cell Bio 2005;37:751-764
12. Rahgozar M, Willgoss DA, Gobé GC, Endre ZH. ATPdependent K- channels in renal ischemia reperfusion injury. Ren Fail 2003;25:885-896
13. Rodriguez-Lopez JM, Sanchez-Conde P, Lozano FS, Nicolás JL, García-Criado FJ, Cascajo C, Muriel C. Laboratory investigation: effects of propofol on the systemic inflammatory response during aortic surgery. Can J Anaesth 2006;53:701-710
14. Basu S, Meisert I, Eggensperger E, Krieger E, Krenn CG. Time course and attenuation of ischaemia-reperfusion induced oxidative injury by propofol in human renal transplantation. Redox Rep 2007;12:195-202
15. Park EJ, Song DK, Cheun JK, Bae JI, Ho WK, Earm YE. Effect of propofol, an intravenous anesthestic agent, on KATP channels of pancreatic--cells in rats. Korean J Physiol Pharmacol 2000;4:25-31
16. Nagawata T, Yamazaki M, Hatakeyama N, Stekiel TA. The mechanisms of propofol-mediated hyperpolarization of in situ rat mesenteric vascular smooth muscle. Anesth Analg 2003;97:1639-1645
17. Barhoumi R, Burghardt RC, Qian Y, Tiffany-Castiglioni E. Effects of propofol on intracellular Ca-2 homeostasis in human astrocytoma cells. Brain Res 2007;1145:11-18
18. Kalkan S, Eminoglu O, Akgun A, Guven H, Tuncok Y. The role of adenosine triphosphate-regulated potassium channels in propofol-induced beneficial effect on contractile function of hypercholesterolemic isolated rabbit hearts. Saudi Med J 2007;28:701-706
19. Kamada N, Kanaya N, Hirata N, Kimura S, Namiki A. Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3-. Can J Anesth 2008;55:595-605
20. Liu KX, Rinne T, He W, Wang F, Xia Z. Propofol attenuates intestinal mucosa injury induced by intestinal ischemiareperfusion in the rat. Can J Anaesth 2007;54:366-374
21. Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Smith LR, Canada AT, Glass PS. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994;81:820-828
22. Cockshott ID. Propofol (Diprivan) pharmacokinetics and metabolism: an overview. Postgrad Med J 1985;61(suppl 3):45-50
23. Morgan DJ, Campbell GA, Crankshaw DP. Pharmacokinetics of propofol when given by intravenous infusion. Br J Clin Pharmacol 1990;30:144-148
24. Joo JD, Kim M, D'Agati VD, Lee HT. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 2006;17:3115-3123
25. Jiang SH, Liu CF, Zhang XL, Xu XH, Zou JZ, Fang Y, Ding XQ. Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation. Cell Biochem Funct 2007;25:335-343
26. Timsit MO, Gadet R, Abdennebi HB, Codas R, Petruzzo P, Badet L. Renal ischemic preconditioning improves recovery of kidney function and decreases alpha-smooth muscle actin expression in a rat model. J Urol 2008;180:388-391
27. Nilakatantan V, Liang H, Maenpaa CJ, Johnson CP. Differential patterns of peroxynitrite mediated apoptosis in proximal tubular epithelial cells following ATP depletion recovery. Apoptosis 2008;13:621-633
28. Canfield PE, Geerdes AM, Molitoris BA. Effect of reversible ATP depletion on tight junction integrity in LLC-PK1 cells. Am J Physiol 1991;261:F1038-45
29. Sanchez-Conde P, Rodriguez-Lopez JM, Nicolás JL, Lozano FS, García-Criado FJ, Cascajo C, González-Sarmiento R, Muriel C. The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesth Analg 2008;106:371-378
30. Broadhead MW, Kharbanda RK, Peters MJ, Macallister RJ. KATP channel activation induces ischemic preconditioning of the endothelium in humans in vivo. Circulation 2004;110:2077-2082
31. Das M, Das DK. Molecular mechanism of preconditioning. IUBMB Life 2008;60:199-203
32. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 2008;77:344-352
33. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 2007;1767:1007-1031
34. Zucchi R, Ghelardoni S, Evangelista S. Biochemical basis of ischemic heart injury and of cardioprotective interventions. Curr Med Chem 2007;14:1619-1637
35. Testai L, Rapposelli S, Calderone V. Cardiac ATP-sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategy. Cardiovasc Hematol Agents Med Chem 2007;5:79-90
36. Cancherini DV, Trabuco LG, Rebouças NA, Kowaltowski AJ. ATP-sensitive K- channels in renal mitochondria. Am J Physiol Renal Physiol 2003;285:F1291-96
37. Sun Z, Zhang X, Ito K, Li Y, Montgomery RA, Tachibana S, Williams GM. Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. Am J Physiol Renal Physiol 2008;294: F491-8
38. Al-Jahdari WS, Saito S, Nakano T, Goto F. Propofol induces growth cone collapse and neurite retractions in chick explant culture. Can J Anaesth 2006;53:1078-1085
39. Chen RM, Wu CH, Chang HC, Wu GJ, Lin YL, Sheu JR, Chen TL. Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology 2003;98:1178-1185
40. Yuzer H, Yuzbasioglu MF, Ciralik H, Kurutas EB, Ozkan OV, Bulbuloglu E, Atli Y, Erdogan O, Kale IT. Effects of intravenous anesthetics on renal ischemia/reperfusion injury. Ren Fail 2009;31:290-296